Publication | Open Access
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
295
Citations
25
References
2009
Year
Phase Ii TrialMedicineCancer ManagementHer2-positive Endometrial CarcinomaGynecologyCancer TreatmentOncologyRadiation OncologyGynecology Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1